series-a
Stage
About
RetinAI develops AI-powered software platforms to manage, analyze, and visualize ophthalmology imaging and clinical data, enabling healthcare professionals, pharmaceutical companies, and researchers to improve disease understanding, patient management, and clinical trials in eye diseases such as AMD, diabetic retinopathy, and glaucoma.
Explore RetinAI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.